Company Filing History:
2 out of 330 
1 out of 1,829 
Years Active: 2002-2007
Title: Alexander Muelsch: Innovator in Soluble Guanylate Cyclase Research
Introduction
Alexander Muelsch is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of soluble guanylate cyclase. With a total of 3 patents, his work focuses on methods for detecting and stimulating the activity of this important enzyme.
Latest Patents
Muelsch's latest patents include innovative methods for screening activators of soluble guanylate cyclase with oxidized heme iron. The first patent describes methods for detecting a soluble guanylate cyclase whose heme iron is in the trivalent oxidation state. It also outlines techniques for identifying chemical substances that enhance the activity of this enzyme when its heme iron is oxidized. Additionally, diagnostic aids or kits for detecting soluble guanylate cyclase with trivalent heme iron are included. The second patent presents a luminescent method for detecting soluble guanylate cyclase, emphasizing similar detection and stimulation techniques as the first patent.
Career Highlights
Throughout his career, Muelsch has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Deutschland GmbH and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to biochemical research.
Collaborations
Some of his notable coworkers include Ursula Schindler and Hartmut Strobel. Their collaborative efforts have contributed to advancements in the understanding of soluble guanylate cyclase and its applications.
Conclusion
Alexander Muelsch's work in the field of soluble guanylate cyclase research showcases his innovative spirit and dedication to advancing biochemistry. His patents reflect a commitment to developing methods that enhance our understanding of this crucial enzyme.